The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable anticipation within the market. A shift away from Schedule I status, often viewed as outdated and hindering https://socialmediatotal.com/story5786658/pot-rescheduling-a-expansion-catalyst